Systemic associations of hidradenitis suppurativa

https://doi.org/10.1016/j.jaad.2015.07.055Get rights and content

Hidradenitis suppurativa (HS) is a progressive, inflammatory disease that affects mostly young women and appears to be caused by inflammation of hair follicles in areas of friction in the body (eg, the axillae, groin, perineum, and medial aspects of the thighs). Given this pathophysiology, one might expect comorbidities that contribute to inflammation and friction. Observed comorbidities fall into several categories: obesity and the metabolic syndrome, hormone-related disorders, deleterious health habits and mood, autoimmune disease, inflammatory disease and finally, the risk of skin cancer and sequelae of nonhealing wounds. The available literature on comorbid diseases of HS is limited but rapidly increasing. In this review, we summarize recent and major studies of HS disease association.

Section snippets

Observations

The available literature on comorbid diseases of hidradenitis suppurativa (HS) is limited but rapidly increasing.1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53 Studies to date suggest that HS is most convincingly associated with the metabolic syndrome (MetS). Associations with many other conditions, including smoking, depression, autoimmune

References (53)

  • M. Braun-Falco et al.

    Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)—a new autoinflammatory syndrome distinct from PAPA syndrome

    J Am Acad Dermatol

    (2012)
  • R. Saraceno et al.

    PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition

    J Am Acad Dermatol

    (2015)
  • J.C. Talmant et al.

    Squamous cell carcinoma arising in Verneuil's disease: two cases and literature review

    Ann Chir Plast Esthet

    (2006)
  • R. Rompel et al.

    Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa

    Dermatol Surg

    (2000)
  • I.M. Miller et al.

    Association of metabolic syndrome and hidradenitis suppurativa

    JAMA Dermatol

    (2014)
  • J.H. Barth et al.

    Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa

    Br J Dermatol

    (1996)
  • K. Sartorius et al.

    Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity

    Br J Dermatol

    (2009)
  • J.J. Crowley et al.

    Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities

    Br J Dermatol

    (2014)
  • C.B. Kromann et al.

    Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study

    Br J Dermatol

    (2014)
  • R. Sabat et al.

    Increased prevalence of metabolic syndrome in patients with acne inversa

    PLoS One

    (2012)
  • S. O'Loughlin et al.

    Hidradenitis suppurativa. Glucose tolerance, clinical, microbiologic, and immunologic features and HLA frequencies in 27 patients

    Arch Dermatol

    (1988)
  • J.H. Barth et al.

    Acanthosis nigricans, insulin resistance and cutaneous virilism

    Br J Dermatol

    (1988)
  • O. Wiltz et al.

    Perianal hidradenitis suppurativa. The Lahey Clinic experience

    Dis Colon Rectum

    (1990)
  • A. Konig et al.

    Cigarette smoking as a triggering factor of hidradenitis suppurativa

    Dermatology

    (1999)
  • J.J. Kohorst et al.

    Treatment experience in a local population with hidradenitis suppurativa

    J Drugs Dermatol

    (2014)
  • E. Shavit et al.

    Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa

    J Eur Acad Dermatol Venereol

    (2015)
  • Cited by (0)

    This publication was supported through funding provided by AbbVie Corporation.

    Conflicts of interest: None declared.

    View full text